US 9096653
Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia
granted A61KA61K39/015A61K47/646
Quick answer
US patent 9096653 (Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K39/015, A61K47/646, A61P, A61P33/06